| Literature DB >> 25257926 |
Ala Al Ali1, Stephen Richmond2, Hashmat Popat2, Arshed M Toma2, Rebecca Playle2, Timothy Pickles2, Alexei I Zhurov2, David Marshall3, Paul L Rosin3, John Henderson4.
Abstract
Three-dimensional (3D) imaging technology has been widely used to analyse facial morphology and has revealed an influence of some medical conditions on craniofacial growth and morphology. The aim of the study is to investigate whether craniofacial morphology is different in atopic Caucasian children compared with controls. Study design included observational longitudinal cohort study. Atopy was diagnosed via skin-prick tests performed at 7.5 years of age. The cohort was followed to 15 years of age as part of the Avon Longitudinal Study of Parents and Children (ALSPAC). A total of 734 atopic and 2829 controls were identified. 3D laser surface facial scans were obtained at 15 years of age. Twenty-one reproducible facial landmarks (x, y, z co-ordinates) were identified on each facial scan. Inter-landmark distances and average facial shells for atopic and non-atopic children were compared with explore differences in face shape between the groups. Both total anterior face height (pg-g, pg-men) and mid-face height (Is-men, sn-men, n-sn) were longer (0.6 and 0.4mm respectively) in atopic children when compared with non-atopic children. No facial differences were detected in the transverse and antero-posterior relationships. Small but statistically significant differences were detected in the total and mid-face height between atopic and non-atopic children. No differences were detected in the transverse and antero-posterior relationships.Entities:
Mesh:
Year: 2013 PMID: 25257926 PMCID: PMC4174908 DOI: 10.1093/ejo/cjs107
Source DB: PubMed Journal: Eur J Orthod ISSN: 0141-5387 Impact factor: 3.075
Figure 1Facial soft tissue landmarks.
Summary of the statistics of 3D co-ordinates.
| Atopic ( | Non-atopic ( | Mean difference | 95% confidence interval | |||
|---|---|---|---|---|---|---|
| Mean | Standard deviation(SD) | Mean | SD | |||
| Eyes Distance (mm, exR–exL) | 87.4 | 3.97 | 87.5 | 4.05 | 0.06 | −0.26–0.39 |
| Nose width (mm, al–al) | 33.8 | 2.86 | 33.6 | 2.68 | −0.18 | −0.40–0.03 |
| Mid-face (mm, ls–men) | 62.0 | 4.22 | 61.6 | 3.95 | −0.45 | −0.79–−0.11 |
| Mid-face (mm, sn–men) | 48.5 | 3.69 | 48.0 | 3.43 | −0.42 | −0.71–−0.13 |
| Mid-face (mm, n–sn) | 52.6 | 3.94 | 52.3 | 3.83 | −0.34 | −0.65–−0.03 |
| Total face height (mm, pg–g) | 114.2 | 6.38 | 113.6 | 6.23 | −0.60 | −1.09–−0.07 |
| Total face height (mm, pg–men) | 94.1 | 5.85 | 93.6 | 5.66 | −0.60 | −1.03–−0.11 |
| Face convexity (angle, n–sn–pg) | 162.0 | 5.51 | 162.5 | 5.64 | 0.41 | −0.04–0.86 |
Figure 2The green areas represent no difference in the atopy and control groups (0mm). The blue area indicates less prominent cheeks and chin point in the atopic group (0.1–0.4mm) the deeper blue representing greater facial retrusion in the atopic group. The yellow areas are those prominent features in the atopic face—prominent forehead, nose, lower lip and wider forehead, nose and lower jaw (0.1–0.5mm).